Danaher Stock Buy or Sell? DHR Stocks Forecast

Market Capitalization: 183 151 591 000 $
EBITDA: 7 368 000 000 $
Price to Earnings: 43.85
Quarterly Earnings Growth YOY: -0.513
Quarterly Revenue Growth YOY: -0.235
Trailing PE: 43.85
Forward PE: 32.47
Shares Outstanding: 739200000

Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

Danaher Stock Buy or Sell? DHR Stocks Analytic Forecasts

Updated on February 27, 2024 (10:19)

Danaher Corp. (DHR prediction charts) Sector: Healthcare

We present you the most up-to-date and complete review of analytical trend forecasts and views on the DHR stock market. Experts share their opinions on what to expect from the Danaher Corp. stock market. How likely is the stock price to move in a bullish or bearish trend. Which should help you to make the right decision whether to Buy or Sell Danaher stocks.

Danaher Corp. Stock Market Experts’ Analysis and Forecasting – Sell or Buy DHR Shares?

The most recent analytical view which can help you to answer the worrying question: Should I Buy Stocks Now or Wait? came out under the authorship of Miguel Daban and is titled

“Danaher: Better Positioned For The Future”

is published on February 3 (2024) and has 0 likes. The review predicts Bullish market trend.

It summarize the following theses:

  • Danaher’s annual results show a decrease in sales and EBIT due to the boost in sales of the COVID-19 pandemic.
  • The company has made strategic acquisitions and spin-offs to improve its business segments and position itself for long-term growth.
  • Danaher’s participation in the J.P. Morgan Annual Healthcare Conference highlighted its recurring demand, potential growth opportunities, and focus on attractive end markets.

The author starts his analytic review with the following:

It’s been 5 months since I published my first article about it Danaher (NYSE:DHR). Many things have happened since then, such as the presentation of annual results or the spin-off of Veralto. This article will aim to summarize all of this and update the thesis, as well as outline the new segments that make up Danaher.

The author declares an interesting position, and the number of his followers is 303 and it grows, but not that weighty compared to other authors.
Miguel Daban has 14 works published.
The contributor of experts community since 2023

One more noteworthy article is written by Leo Nelissen under the title

“Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term”

on January 30 (2024) and has 3 likes. The expert reflects Bullish trend of the market.

Нis theses make you think about whether to add DHR stocks to your investment portfolio or not, and helps to work out your own Danaher stock selling strategies:

  • Despite recent challenges, Danaher remains resilient and strategically positioned for long-term success.
  • Danaher’s 4Q23 results, while showing declines, highlight strategic steps and acquisitions, setting the stage for sustained growth.
  • Despite hurdles, my confidence in DHR stock is unwavering. The company’s track record and proactive measures make it a robust investment, with plans to seize opportunities in stock price weaknesses.

Leo Nelissen starts analysis with such words:

Introduction It’s time to talk about one of my favorite investments. My most recent article on the Danaher Corporation (NYSE:DHR) was written on October 26, when I used the title “Why Danaher Is One Of My Favorite Long-Term Investments.”

This author is very popular among the auditory. He has 29847 followers

Leo Nelissen is the contributor of experts community since 2015. Has published at least 2517 articles.

Another analysis presented by Greathouse Research came out on December 28 (2023). Obviously, coupled with the newer reviews, this forecasting could be useful to find out the best trading strategy for DHR stocks. It sounds like

“Danaher: Continuously Compounding”

Article has got 1 likes at the moment and forecasting Bullish trend of the market.

Summarizing the information presented in the review concerning the Danaher Corp., the expert says the following:

  • Danaher has undergone a radical transformation from a real estate trust to a leader in the life sciences industry through strategic acquisitions.
  • The company’s focus on continuous improvement and efficiency, guided by the Kaizen philosophy, has been a driving force behind its success.
  • Danaher’s recent divestments and increased focus on its core businesses have led to strong financial performance and growth, making it an attractive investment option.

And here, what comes first:

Introduction As a long-term-oriented investor, I’m always searching for companies that also orient themselves to the long term. There are many ways you can measure that, and yes, it is somewhat subjective. But I believe few companies do it better and more decisively than Danaher (NYSE:DHR).

Greathouse Research has already 1484 followers, which shows, he is the one who cares for his words.
The contributor of experts community since 2022. Has already 87 analytic reviews published.

The Share Price of Danaher Corp. (DHR) for now

What analysts predict: $260.7
52-week high/low: $252.33 / $181.9

50/200 Day Moving Average: $233.89 / $219.14

The average stock price over the previous 50/200 days. For Danaher stocks, the 50-day moving average is the resistance level for now. For DHR stocks, the 200-day moving average is the resistance level today.

See the Detailed Predictions for DHR stock with charts and tables

Related Analysis

View all analytics

Buy or Sell ADGI shares?
January 1, 1970

Thermo Fisher’s Bright Future Makes It A Great Buy On Weakness

Buy or Sell TMO shares? Thermo Fisher’s Bright Future Makes It A Great Buy On Weakness
February 6, 2024
Drug manufacturers are facing a massive patent cliff, with over $200 billion in annual revenue at risk through 2030, meaning innovation is critical to prop up sales, and today's company focuses on that.

Revisiting Zynerba Pharmaceuticals

Buy or Sell ZYNE shares? Revisiting Zynerba Pharmaceuticals
November 11, 2021
Today, we revisit a small developmental firm called Zynerba Pharmaceuticals.